Agha, ME
Cohen, AD
Madduri, D
Cohen, YC
Delforge, M
Hillengass, J
Goldschmidt, H
Weisel, K
Raab, M
Scheid, C
Schecter, JM
Braganca, KC
Varsos, H
Wang, L
Vogel, M
Carrasco-Alfonso, MJ
Akram, M
Wu, X
Nesheiwat, T
Einsele, H
This article is maintained by: Elsevier
Article Title: EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER 1–3 PRIOR LINES OF THERAPY: CARTITUDE-2 PHASE 2 STUDY
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2021.10.433
Content Type: simple-article
Copyright: Copyright © 2021 Published by Elsevier Editora Ltda.